131 related articles for article (PubMed ID: 16878320)
1. Inhibition of proteasome and Shaggy/Glycogen synthase kinase-3beta kinase prevents clearance of phosphorylated tau in Drosophila.
Blard O; Frébourg T; Campion D; Lecourtois M
J Neurosci Res; 2006 Oct; 84(5):1107-15. PubMed ID: 16878320
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.
Chatterjee S; Sang TK; Lawless GM; Jackson GR
Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
4. ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation.
Resende R; Ferreiro E; Pereira C; Oliveira CR
J Neurosci Res; 2008 Jul; 86(9):2091-9. PubMed ID: 18335524
[TBL] [Abstract][Full Text] [Related]
5. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
6. TPPU protects tau from H
Yao ES; Tang Y; Liu XH; Wang MH
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):785-790. PubMed ID: 27924507
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition-induced downregulation of Akt/GSK-3β pathway contributes to abnormality of tau in hippocampal slice.
Xie M; Shi R; Pan Y; Zeng T; Chen Q; Wang S; Liao X
Mol Neurobiol; 2014 Dec; 50(3):888-95. PubMed ID: 24752588
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibition increases tau accumulation independent of phosphorylation.
Liu YH; Wei W; Yin J; Liu GP; Wang Q; Cao FY; Wang JZ
Neurobiol Aging; 2009 Dec; 30(12):1949-61. PubMed ID: 18403053
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
[TBL] [Abstract][Full Text] [Related]
12. Shaggy/glycogen synthase kinase 3β and phosphorylation of Sarah/regulator of calcineurin are essential for completion of Drosophila female meiosis.
Takeo S; Swanson SK; Nandanan K; Nakai Y; Aigaki T; Washburn MP; Florens L; Hawley RS
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6382-9. PubMed ID: 22421435
[TBL] [Abstract][Full Text] [Related]
13. GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila.
Mudher A; Shepherd D; Newman TA; Mildren P; Jukes JP; Squire A; Mears A; Drummond JA; Berg S; MacKay D; Asuni AA; Bhat R; Lovestone S
Mol Psychiatry; 2004 May; 9(5):522-30. PubMed ID: 14993907
[TBL] [Abstract][Full Text] [Related]
14. Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo.
Lu J; Miao J; Su T; Liu Y; He R
Biochim Biophys Acta; 2013 Aug; 1830(8):4102-16. PubMed ID: 23628704
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3β.
Kawakami F; Suzuki M; Shimada N; Kagiya G; Ohta E; Tamura K; Maruyama H; Ichikawa T
FEBS J; 2011 Dec; 278(24):4895-904. PubMed ID: 21985244
[TBL] [Abstract][Full Text] [Related]
16. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the mouse dishevelled-1 protein inhibits GSK-3beta-mediated phosphorylation of tau in transfected mammalian cells.
Wagner U; Brownlees J; Irving NG; Lucas FR; Salinas PC; Miller CC
FEBS Lett; 1997 Jul; 411(2-3):369-72. PubMed ID: 9271238
[TBL] [Abstract][Full Text] [Related]
18. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
19. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
Hu M; Waring JF; Gopalakrishnan M; Li J
J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
[TBL] [Abstract][Full Text] [Related]
20. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
